Registration: opens March 2016
Aims of APCCC 2017
In advanced prostate cancer, rapid and successful drug development has resulted in multiple treatment options, requiring careful decision making for individual patients. Clinicians face the increasingly difficult task of choosing from multiple potentially effective treatments that are also costly and potentially toxic.
The inaugural Advanced Prostate Cancer Consensus Conference (APCCC) did provide a forum for discussion and debates on current treatment options for men with advanced prostate cancer. The conference concluded with voting by the panel on pre-defined consensus questions, targeting areas of primary clinical relevance. Following the conference a manuscript with containing the expert recommendations was published at Annals of Oncology.